cdmo.directory
← Compare landing

Micromacinazione vs 重庆兴泰濠制药有限公司 (Sintaho)

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/micromacinazione/sintaho

CategoryMicromacinazione重庆兴泰濠制药有限公司 (Sintaho)
Listed sitecdmocdmo
SummarySwiss-based CDMO specializing in particle engineering and micronization with over 50 years of experience. Offers micronization, milling, spray drying, solid-state characterization, and complementary processing services (classification, blending, cryogenic, co-micronization, conditioning) for APIs, HPAPIs, controlled substances, and excipients from early development to commercial GMP scale.China-based API and CDMO/CMO supplier focused on cytotoxic and OEB5 high-potency APIs, peptides, and XDC compounds. Reports FDA on-site inspections in 2024 and 2025 and product registrations in more than 30 countries.
Services
  • Process Development
  • CMC Analytical Development
  • Solid-State Chemistry & Polymorph Screening
  • HPAPI Manufacturing (High-Potency)
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Peptide Manufacturing
  • Small Molecule Development & Manufacturing
Modalities
  • Small Molecule
  • Small Molecule
  • Peptide
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Monteggio, Ticino, Switzerland
  • US Operations, Quakertown, Pennsylvania, USA
  • Headquarters, Chongqing, Chongqing, China
Certifications
  • GMP · Identifier: GMP-inspected production facilities
  • Internet Drug Information Service Qualification (Chongqing) · Identifier: （渝）-非经营性-2022-0020
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.